A phase I factorial design study of dose-dense temozolomide alone and in combination with thalidomide, isotretinoin, and/or celecoxib as postchemoradiation adjuvant therapy for newly diagnosed glioblastoma.
Autor: | Gilbert, Mark R., Gonzalez, Javier, Hunter, Kathy, Hess, Kenneth, Giglio, Pierre, Chang, Eric, Puduvalli, Vinay, Groves, Morris D., Colman, Howard, Conrad, Charles, Levin, Victor, Woo, Shaio, Mahajan, Anita, de Groot, John, Yung, W.K. Alfred |
---|---|
Zdroj: | Neuro-Oncology; Nov2010, Vol. 12 Issue 11, p1167-1172, 6p, 1 Diagram, 3 Charts, 1 Graph |
Databáze: | Complementary Index |
Externí odkaz: |